Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Cardiac Effects of Rosiglitazone in Male Wistar Rats


ABSTRACT: Rosiglitazone, a peroxisome proliferator-activated receptor g (PPARg) agonist of the thiazolidinedione class, is a major insulin-sensitizing drug widely used to treat type-2 diabetes. Rosiglitazone causes myocardial hypertrophy in rodents and increases the risk of cardiac events in man. To better characterize its cardiac effects, male Wistar rats were orally administered 0, 10 or 80 mg/kg/day rosiglitazone. Male Wistar rats were orally administered 0, 10 or 80 mg/kg/day rosiglitazone once per day for 14 days. Samples were obtained 6, 24, 168 or 336 hours after the final treatment.

ORGANISM(S): Rattus norvegicus

SUBMITTER: Charu Kanwal 

PROVIDER: E-GEOD-22553 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2010-06-25 | GSE22553 | GEO
2010-06-25 | GSE22553 | GEO
2018-04-18 | PXD004504 | Pride
2020-12-21 | GSE158713 | GEO
2023-01-09 | GSE193504 | GEO
2011-03-18 | GSE28031 | GEO
2016-09-01 | E-GEOD-73387 | biostudies-arrayexpress
2012-07-13 | E-GEOD-39344 | biostudies-arrayexpress
2018-04-11 | GSE109728 | GEO
2022-06-01 | GSE168232 | GEO